What happens when you take simvastatin with st. john's wort?
Simvastatin (Zocor, FloLipid) is a prodrug: you swallow an inactive lactone that the body converts to simvastatin hydroxy acid, the form that actually inhibits cholesterol synthesis. That conversion and the drug's overall clearance run almost entirely through CYP3A4 in the gut wall and liver, and the drug is also a substrate for the P-glycoprotein efflux pump in the intestine.
St. John's wort (Hypericum perforatum) potently induces both CYP3A4 and P-glycoprotein after about two weeks of daily use. The net effect on simvastatin is dramatic: less drug makes it past the gut and liver, and what does get through is cleared faster.
In a randomized, double-blind crossover study, 16 healthy men took St. John's wort 300 mg three times daily (or matching placebo) for 14 days, then a single 10 mg dose of simvastatin. The AUC of simvastatin hydroxy acid dropped to roughly 48% of placebo — essentially cut in half — when St. John's wort was on board.
Why is this important?
Simvastatin's job is to keep LDL cholesterol below a target your clinician has set, often after a heart attack, stroke, or diabetes diagnosis. Losing half of the active drug exposure means losing a meaningful chunk of LDL lowering. You will not feel anything different in the moment, but your cardiovascular risk creeps back up while you assume you are still protected.
The interaction is also one of the better-studied herbal–statin interactions, so it is not a theoretical concern: the AUC drop has been reproduced and the mechanism (CYP3A4 + P-gp induction) is well understood. Many people take St. John's wort for low mood without telling their doctor, which makes the lost statin effect easy to miss.
Hyperforin content drives most of the induction, and over-the-counter St. John's wort products vary widely in standardization. There is no safe product to pair with simvastatin.
What should you do?
If you are on simvastatin for cholesterol, don't start or continue St. John's wort. If you are currently taking both, stop the St. John's wort and tell your prescriber. CYP3A4 activity normalizes over one to two weeks after the herb is discontinued, so plan a follow-up lipid panel about four weeks later to confirm your LDL is back on target.
If you and your clinician decide St. John's wort is genuinely needed, ask about switching to a statin that doesn't depend on CYP3A4 — pravastatin, rosuvastatin, or pitavastatin are typical alternatives. Recheck lipids within four to six weeks of the switch.
If you are using St. John's wort for low mood, please don't self-treat indefinitely. Mild-to-moderate depression has many evidence-based options (therapy, exercise, SSRIs) that don't fight with your cardiovascular medications. A primary care visit to discuss what you're treating is worth more than the herb.
Which specific products are affected?
This applies to any branded or generic simvastatin, including Zocor, FloLipid (oral suspension), and combination products such as Vytorin (simvastatin + ezetimibe). The interaction is also expected with lovastatin (Mevacor, Altoprev), which shares the same CYP3A4-dependent metabolism, even though lovastatin was not the drug studied.
On the herbal side, the published data come from standardized St. John's wort extracts (300 mg three times daily, typical of European preparations like LI 160), but any St. John's wort product — capsules, tablets, tinctures, teas, gummies, or multi-ingredient "mood support" or "stress" blends — should be assumed to carry the same risk. Check supplement labels carefully, as Hypericum perforatum can be a non-headline ingredient.
By contrast, pravastatin, rosuvastatin, fluvastatin, and pitavastatin do not rely heavily on CYP3A4 and are far less affected, although some signal has been reported for rosuvastatin via transporter effects.
The bottom line
St. John's wort can cut your effective simvastatin exposure roughly in half by inducing CYP3A4 and P-glycoprotein. Avoid the combination. If you need the herb, switch to a non-CYP3A4 statin under medical supervision and recheck lipids within a month or so.